Key Insights

Highlights

Success Rate

84% trial completion

Published Results

23 trials with published results (32%)

Research Maturity

53 completed trials (73% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 39/100

Termination Rate

13.7%

10 terminated out of 73 trials

Success Rate

84.1%

-2.4% vs benchmark

Late-Stage Pipeline

33%

24 trials in Phase 3/4

Results Transparency

43%

23 of 53 completed with results

Key Signals

23 with results84% success

Data Visualizations

Phase Distribution

63Total
Not Applicable (26)
P 1 (6)
P 2 (7)
P 3 (5)
P 4 (19)

Trial Status

Completed53
Terminated10
Unknown7
Recruiting1
Withdrawn1
Not Yet Recruiting1

Trial Success Rate

84.1%

Benchmark: 86.5%

Based on 53 completed trials

Clinical Trials (73)

Showing 20 of 20 trials
NCT07263022Phase 3Not Yet Recruiting

Cognitive Strategies in Early Psychosis 2

NCT04013555Phase 1Completed

The Effects of Kynurenine Aminotransferase Inhibition in People With Schizophrenia

NCT05890183Not ApplicableRecruiting

Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode

NCT01602029Phase 2Completed

Randomized Double Blind Placebo Control Study in Patients with Schizophrenia

NCT01029769Not ApplicableCompleted

Efficacy of an Early Antipsychotic Switch in Case of Poor Initial Response to the Treatment of Schizophrenia

NCT03201757Phase 3Completed

Study to Evaluate the Long-term Safety, Tolerability, and Durability of Treatment Effect of ALKS 3831

NCT01425671Completed

Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States

NCT01764568Not ApplicableTerminated

Contrasting Group Therapy Methods for Psychosis

NCT01481883Phase 4Completed

Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men?

NCT04203056Phase 4Terminated

Aripiprazole Lauroxil for Preventing Psychotic Relapse After an Initial Schizophrenia Episode

NCT02823041Not ApplicableCompleted

Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode

NCT02131129Not ApplicableCompleted

rTMS in First Episode Psychosis

NCT00716755Not ApplicableCompleted

Minimizing Doses of Antipsychotic Medication in Older Patients With Schizophrenia.

NCT02533232Phase 1Unknown

Minocycline Augmentation of Clozapine for Treatment Resistant Schizophrenia

NCT00492349Phase 4Completed

Varenicline Adjunctive Treatment in Schizophrenia

NCT01321177Not ApplicableCompleted

An Integrated Program for the Treatment of First Episode of Psychosis

NCT03043820Phase 3Completed

Raloxifene Augmentation in Patients With a Schizophrenia Spectrum Disorder

NCT01866098Not ApplicableCompleted

Naltrexone for Antipsychotic-Induced Weight Gain

NCT01888627Not ApplicableUnknown

Integrated Care in Psychotic Disorders With Severe Mental Illness

NCT01425684Completed

Brain Circuits in Schizophrenia and Smoking

Scroll to load more

Research Network

Activity Timeline